CIK 0002130606 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-05 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-09-09 | EFFECT | EFFECT items ,, | |
| 2026-08-28 | S-1 | S-1 | |
| 2026-08-14 | 8-K/A | 8-K/A items 9.01 | 2026-07-31 |
| 2026-08-14 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-11 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-10 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-10 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-10 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-05 | 4 | 4 | 2026-08-03 |
| 2026-08-05 | 4 | 4 | 2026-08-03 |
| 2026-08-05 | 4 | 4 | 2026-08-03 |
| 2026-08-05 | 4 | 4 | 2026-08-03 |
| 2026-08-05 | 4 | 4 | 2026-08-03 |
| 2026-08-05 | 4 | 4 | 2026-08-03 |
| 2026-08-03 | 3 | 3 | 2026-08-03 |
| 2026-08-03 | 3 | 3 | 2026-08-03 |
| 2026-08-03 | 3 | 3 | 2026-08-03 |
| 2026-08-03 | 3 | 3 | 2026-08-03 |
| 2026-08-03 | 3 | 3 | 2026-08-03 |
| 2026-08-03 | 3 | 3 | 2026-08-03 |
| 2026-08-03 | 3 | 3 | 2026-08-03 |
| 2026-08-03 | 3 | 3 | 2026-08-03 |
| 2026-08-03 | S-8 | S-8 | |
| 2026-08-03 | 8-K | 8-K items 1.01,2.01,2.02,3.02,3.03,4.01,5.01,5.02,5.03,7.01,9.01 | 2026-07-31 |
Forms on file (last 1,000): 3 8, 4 6, SCHEDULE 13G 5, S-4/A 4, EFFECT 2, S-1 1, 8-K/A 1, 10-Q 1. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=OBX (0.002 USD), /gw/filings/filings?ticker=OBX&form=8-K, /gw/filings/facts?ticker=OBX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange